Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HMGN1P8 (high mobility group nucleosome binding domain 1 pseudogene 8) is one of several processed pseudogenes related to the HMGN1 gene and mapped in the human genome. The functional HMGN1 gene encodes a chromatin-associated protein involved in nucleosome binding and regulation of chromatin structure, but HMGN1P8 lacks protein-coding potential and is not known to be transcribed or translated into a functional product. Unlike other characterized pseudogenes from related high mobility group protein families (such as the HMGA1 pseudogenes, which can influence gene regulation or participate in disease processes), no biological or clinical function has been attributed to HMGN1P8, and it is not a subject of therapeutic research. Therefore, HMGN1P8 is best considered an uncharacterized genomic remnant rather than a molecular or clinical target. Note: Many pseudogenes are being studied for potential regulatory roles; if new evidence emerges for HMGN1P8, it could be reclassified.
Not applicable; no drugs target this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group nucleosome binding domain 1 pseudogene 8 (HMGN1P8).